Press Releases Latest May 02, 2024 Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting Press Releases Year None202420232022202120202019201820172016201520142013 Jun 30, 2021 Theratechnologies to Announce Financial Results for Its Second Quarter Fiscal 2021 Jun 23, 2021 Theratechnologies Appoints New Board Member Jun 21, 2021 Theratechnologies Announces New Preclinical Findings for Its Lead Investigational Peptide-Drug Conjugate TH1902 for the Potential Treatment of Metastatic Cancers Jun 10, 2021 Theratechnologies to Host Key Opinion Leader Event to Discuss its SORT1+ Technology™ for the Treatment of All Sortilin-Expressing Cancers May 31, 2021 Theratechnologies Hires Vice President, Human Resources May 20, 2021 Theratechnologies Announces Results From Two Posters Presented at ACTHIV 2021 Annual Meeting Highlighting Positive Patient Experience With Trogarzo® May 18, 2021 Theratechnologies to Participate in Virtual Fireside Chat With Canaccord Genuity on May 20, 2021 May 13, 2021 Announcements in Conjunction With Theratechnologies Annual Meeting Apr 14, 2021 Theratechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights Apr 12, 2021 Theratechnologies to Present at the Bloom Burton & Co. Healthcare Investor Conference First page « Previous page ‹ … Page 8 Page 9 Page 10 Page 11 Current page 12 Page 13 Page 14 Page 15 Page 16 … Next page › Last page » Displaying 111 - 120 of 361
May 02, 2024 Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
Jun 21, 2021 Theratechnologies Announces New Preclinical Findings for Its Lead Investigational Peptide-Drug Conjugate TH1902 for the Potential Treatment of Metastatic Cancers
Jun 10, 2021 Theratechnologies to Host Key Opinion Leader Event to Discuss its SORT1+ Technology™ for the Treatment of All Sortilin-Expressing Cancers
May 20, 2021 Theratechnologies Announces Results From Two Posters Presented at ACTHIV 2021 Annual Meeting Highlighting Positive Patient Experience With Trogarzo®
May 18, 2021 Theratechnologies to Participate in Virtual Fireside Chat With Canaccord Genuity on May 20, 2021
Apr 14, 2021 Theratechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights